Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to -$7.9 million.

  • Pediatrix Medical's Change in Receivables fell 40159.34% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.8 million, marking a year-over-year decrease of 70477.57%. This contributed to the annual value of -$10.3 million for FY2024, which is 6083.12% up from last year.
  • Pediatrix Medical's Change in Receivables amounted to -$7.9 million in Q3 2025, which was down 40159.34% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Change in Receivables ranged from a high of $30.7 million in Q4 2021 and a low of -$21.3 million during Q1 2023
  • Its 5-year average for Change in Receivables is $663421.1, with a median of -$3.8 million in 2025.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 601217.71% in 2021, then plummeted by 40159.34% in 2025.
  • Over the past 5 years, Pediatrix Medical's Change in Receivables (Quarter) stood at $30.7 million in 2021, then tumbled by 83.58% to $5.0 million in 2022, then plummeted by 182.92% to -$4.2 million in 2023, then plummeted by 130.97% to -$9.7 million in 2024, then grew by 18.5% to -$7.9 million in 2025.
  • Its Change in Receivables stands at -$7.9 million for Q3 2025, versus -$3.8 million for Q2 2025 and -$17.5 million for Q1 2025.